Products
News
Resources
Contact
Language
简体中文
繁體中文
English
日本語
한국어
Tiếng Việt
Overview
Latest
Regional
Industry
Featured
Multimedia
Other Languages
Public Company News
All
APAC
Global
All
APAC
Global
All
APAC
Global
All
APAC
Global
{{toptitleLeft}}
{{toptitleRight}}
{{selectTitle}}
{{toptitleLeft}}
{{index}}
{{select_list_per.name}}
Time
{{showName}}
{{weixin_name}}
X
{{listname}}
Loading
Network Errors Please Retry
{{storydata.story.headline}}
{{storydata.story.date_time}}
{{storydata.story.click_num}}
loading
The End
Network Errors Please Retry
loading
Network Errors Please Retry
{{storydata.headline}}
{{storydata.create_time}}
{{storydata.headline}}
{{storydata.create_time}}
loading
The End
Network Errors Please Retry
loading
Network Errors Please Retry
{{storydata.story.headline}}
{{storydata.story.date_time}}
{{storydata.story.click_num}}
{{storydata.story.headline}}
{{storydata.story.date_time}}
{{storydata.story.click_num}}
loading
The End
Network Errors Please Retry
loading
Network Errors Please Retry
{{storydata.story.headline}}
{{storydata.story.date_time}}
{{storydata.story.click_num}}
{{theme.pcom_theme_name}}
{{storydata.story.headline}}
{{storydata.story.date_time}}
{{storydata.story.click_num}}
{{theme.pcom_theme_name}}
loading
The End
Network Errors Please Retry
Insilico Medicine Announces Novel 3CL Protease Inhibitor Preclinical Candidate for COVID-19 Treatment
2022-05-24 21:00
New Study Shows Critical Role of 1,5-Anhydroglucitol (1,5-AG) in COVID-19 Pathogenesis by Binding to the COVID-19 Spike Protein
2022-05-24 19:00
WHO Goodwill Ambassador for Leprosy Elimination Recognized with WHO Director-General's Award for Global Health at 75th World Health Assembly
2022-05-23 00:00
CanSinoBIO's COVID-19 Vaccine Convidecia™ Receives WHO Emergency Use Listing
2022-05-19 23:28
PostEra spearheads AI-driven drug discovery collaboration to develop antiviral therapeutics with initial $68M in NIH funding
2022-05-19 04:56
Ascentage Pharma Announces Preclinical Data Demonstrating Olverembatinib's Therapeutic Potential in Treating COVID-19 Published in EMBO Molecular Medicine
2022-05-18 22:06
SIMCERE PHARMA (HK.2096) Novel Inhibitor of COVID-19 3CLpro SIM0417 Received a Second Clinical Trial Approval in China
2022-05-18 11:56
ASEAN to build its own CDC to mitigate another pandemic risk
2022-05-18 09:00
ASEAN accepts mutually recognized COVID-19 vaccination certificates
2022-05-17 19:14
NEW GUIDELINES FOR COVID TESTING
2022-05-13 17:10
Yiling Pharmaceutical: Lianhua Qingwen Approved in Nigeria
2022-05-12 22:43
ECCMID 2022: Copan unveils its WISE approach to sample management
2022-05-12 20:25
A novel universal antiviral drug introduced in Korea
2022-05-12 18:19
HKBN Receives Amazon Web Services' HK Managed Service Award
2022-05-11 11:49
U.S. Centers for Disease Control and Prevention Selects Biobot Analytics to Expand National Wastewater Monitoring
2022-05-10 00:00
Brii Bio Reports Progress on ESG Commitments in Its Inaugural ESG Report
2022-05-07 09:00
SICPA AND THE BATAILLON DE MARINS-POMPIERS DE MARSEILLE ARE TESTING AN INNOVATIVE SOLUTION FOR DETECTING PATHOGENS IN AIRCRAFT WASTEWATER
2022-05-06 14:00
Promising COVID oral antiviral being co-researched by Healion Bio and FUJIFILM Toyama
2022-04-29 01:00
FDA Approves Direct Biologics to Proceed with a Landmark Phase 3 Acute Respiratory Distress Syndrome (ARDS) Trial
2022-04-27 00:09
The First International COVID-19 Testing Standard Released
2022-04-26 13:02
1
14
15
16
17
18
91